Evidence map›Paper›PMID 41596432›Full record

ReviewInternational journal of molecular sciences2026

Bone Metastasis in Estrogen Receptor-Positive Breast Cancer: Molecular Insights and Therapeutic Advances.

Zhuoran Huang, Yi Wu, Yanshu Li

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zhuoran HuangSchool of Medicine, China Medical University, Shenyang 110122, China.ORCID 0009-0006-9356-0411
Yi WuDepartment of Pathogenic Biology, Shenyang Medical College, Shenyang 110034, China.
Yanshu LiDepartment of Cell Biology, Key Laboratory of Cell Biology, Ministry of Public Health, and Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang 110122, China.ORCID 0000-0003-4500-9247

Funding

National Natural Science Foundation of China 81902701Natural Science Foundation of Liaoning Province under Grant 2023JH2/20200036
6 · The paper itself

Abstract

Estrogen receptor-positive (ER

Indexed as

Bone NeoplasmsBreast NeoplasmsReceptors, EstrogenAnimalsFemaleHumansSignal TransductionTumor MicroenvironmentReceptors, Estrogenbone metastasisCDK4/6 inhibitorsendocrine resistanceestrogen receptor-positive breast cancerprecision medicinesignal transductiontargeted therapytumor microenvironment

Identifiers

PMID41596432
PMCPMC12841352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.